Trial · NCT01727336
Adverse events678
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 678
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Part 1: Dalantercept 0.6 mg/kg | 2 | 6 | 2 |
| other | Diarrhoea | Gastrointestinal disorders | Part 1: Dalantercept 0.9 mg/kg | 4 | 9 | 4 |
| other | Diarrhoea | Gastrointestinal disorders | Part 1: Dalantercept 1.2 mg/kg | 6 | 14 | 6 |
| other | Diarrhoea | Gastrointestinal disorders | Part 1: Dalantercept 1.5 mg/kg | 0 | 0 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 54 | 62 | 54 |
| other | Diarrhoea | Gastrointestinal disorders | Part 2: Placebo Plus Axitinib | 55 | 64 | 55 |
| other | Nausea | Gastrointestinal disorders | Part 1: Dalantercept 0.6 mg/kg | 2 | 6 | 2 |
| other | Nausea | Gastrointestinal disorders | Part 1: Dalantercept 0.9 mg/kg | 3 | 9 | 3 |
| other | Nausea | Gastrointestinal disorders | Part 1: Dalantercept 1.2 mg/kg | 3 | 14 | 3 |
| other | Nausea | Gastrointestinal disorders | Part 1: Dalantercept 1.5 mg/kg | 0 | 0 | |
| other | Nausea | Gastrointestinal disorders | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 38 | 62 | 38 |
| other | Nausea | Gastrointestinal disorders | Part 2: Placebo Plus Axitinib | 40 | 64 | 40 |
| other | Constipation | Gastrointestinal disorders | Part 1: Dalantercept 0.6 mg/kg | 1 | 6 | 1 |
| other | Constipation | Gastrointestinal disorders | Part 1: Dalantercept 0.9 mg/kg | 3 | 9 | 3 |
| other | Constipation | Gastrointestinal disorders | Part 1: Dalantercept 1.2 mg/kg | 0 | 14 | |
| other | Constipation | Gastrointestinal disorders | Part 1: Dalantercept 1.5 mg/kg | 0 | 0 | |
| other | Constipation | Gastrointestinal disorders | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 24 | 62 | 24 |
| other | Constipation | Gastrointestinal disorders | Part 2: Placebo Plus Axitinib | 28 | 64 | 28 |
| other | Vomiting | Gastrointestinal disorders | Part 1: Dalantercept 0.6 mg/kg | 0 | 6 | |
| other | Vomiting | Gastrointestinal disorders | Part 1: Dalantercept 0.9 mg/kg | 0 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01727336/events